Table 3.
Clinical efficacy evaluation of the 4 groups of patients before and at the last follow-up.
Group | Harris hip score | t | P | |
---|---|---|---|---|
Preoperative | Last follow-up | |||
Group A (n = 20, 20 hips) | 32.39 ± 14.66 | 92.33 ± 4.75 | 18.942 | ≤0.001 |
Group B (n = 19, 20 hips) | 30.25 ± 18.79 | 94.13 ± 4.25 | 16.916 | ≤0.001 |
Group C (n = 19, 20 hips) | 31.53 ± 20.13 | 94.25 ± 3.10 | 14.907 | ≤0.001 |
Group D (n = 20, 20 hips) | 31.61 ± 18.88 | 94.30 ± 2.61 | 14.688 | ≤0.001 |